Literature DB >> 27716898

Distinct patterns of cytolytic T-cell activation by different tumour cells revealed by Ca2+ signalling and granule mobilization.

Melissa Frick1, Pierre Mouchacca1, Grégory Verdeil1, Yannick Hamon1, Cyrille Billaudeau1, Michel Buferne1, Mathieu Fallet1, Nathalie Auphan-Anezin1, Anne-Marie Schmitt-Verhulst1, Claude Boyer1.   

Abstract

Cancer-germline genes in both humans and mice have been shown to encode antigens susceptible to targeting by cytotoxic CD8 T effector cells (CTL). We analysed the ability of CTL to kill different tumour cell lines expressing the same cancer-germline gene P1A (Trap1a). We previously demonstrated that CTL expressing a T-cell receptor specific for the P1A35-43 peptide associated with H-2Ld , although able to induce regression of P1A-expressing P815 mastocytoma cells, were much less effective against P1A-expressing melanoma cells. Here, we analysed parameters of the in vitro interaction between P1A-specific CTL and mastocytoma or melanoma cells expressing similar levels of the P1A gene and of surface H-2Ld . The mastocytoma cells were more sensitive to cytolysis than the melanoma cells in vitro. Analysis by video-microscopy of early events required for target cell killing showed that similar patterns of increase in cytoplasmic Ca2+ concentration ([Ca2+ ]i) were induced by both types of P1A-expressing tumour cells. However, the use of CTL expressing a fluorescent granzyme B (GZMB-Tom) showed a delay in the migration of cytotoxic granules to the tumour interaction site, as well as a partially deficient GZMB-Tom exocytosis in response to the melanoma cells. Among surface molecules possibly affecting tumour-CTL interactions, the mastocytoma cells were found to express intercellular adhesion molecule-1, the ligand for LFA-1, which was not detected on the melanoma cells.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  cytolytic T lymphocyte; fluorescent granzyme B; melanoma; tumour

Mesh:

Substances:

Year:  2016        PMID: 27716898      PMCID: PMC5214755          DOI: 10.1111/imm.12679

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  63 in total

1.  Thymocyte-intrinsic genetic factors influence CD8 T cell lineage commitment and affect selection of a tumor-reactive TCR.

Authors:  Anil Shanker; Nathalie Auphan-Anezin; Patrick Chomez; Laurent Giraudo; Benoît Van den Eynde; Anne-Marie Schmitt-Verhulst
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

2.  Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: manifestation of a dual activation threshold.

Authors:  Mustapha Faroudi; Clemens Utzny; Mariolina Salio; Vincenzo Cerundolo; Martine Guiraud; Sabina Müller; Salvatore Valitutti
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

3.  Faithful activation of an extra-bright red fluorescent protein in "knock-in" Cre-reporter mice ideally suited for lineage tracing studies.

Authors:  Hervé Luche; Odile Weber; Tata Nageswara Rao; Carmen Blum; Hans Jörg Fehling
Journal:  Eur J Immunol       Date:  2007-01       Impact factor: 5.532

4.  Vascular normalization in Rgs5-deficient tumours promotes immune destruction.

Authors:  Juliana Hamzah; Manfred Jugold; Fabian Kiessling; Paul Rigby; Mitali Manzur; Hugo H Marti; Tamer Rabie; Sylvia Kaden; Hermann-Josef Gröne; Günter J Hämmerling; Bernd Arnold; Ruth Ganss
Journal:  Nature       Date:  2008-04-16       Impact factor: 49.962

5.  IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers.

Authors:  Bin Zhang; Theodore Karrison; Donald A Rowley; Hans Schreiber
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

6.  LFA-1-dependent Ca2+ entry following suboptimal T cell receptor triggering proceeds without mobilization of intracellular Ca2+.

Authors:  Kwangmi Kim; Lin Wang; Inkyu Hwang
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

7.  IFNγ producing CD8+ T cells modified to resist major immune checkpoints induce regression of MHC class I-deficient melanomas.

Authors:  Michel Buferne; Lionel Chasson; Magali Grange; Amandine Mas; Fanny Arnoux; Mélanie Bertuzzi; Philippe Naquet; Lee Leserman; Anne-Marie Schmitt-Verhulst; Nathalie Auphan-Anezin
Journal:  Oncoimmunology       Date:  2015-03-06       Impact factor: 8.110

8.  PD-1 blockade induces responses by inhibiting adaptive immune resistance.

Authors:  Paul C Tumeh; Christina L Harview; Jennifer H Yearley; I Peter Shintaku; Emma J M Taylor; Lidia Robert; Bartosz Chmielowski; Marko Spasic; Gina Henry; Voicu Ciobanu; Alisha N West; Manuel Carmona; Christine Kivork; Elizabeth Seja; Grace Cherry; Antonio J Gutierrez; Tristan R Grogan; Christine Mateus; Gorana Tomasic; John A Glaspy; Ryan O Emerson; Harlan Robins; Robert H Pierce; David A Elashoff; Caroline Robert; Antoni Ribas
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

9.  Visualization of cytolytic T cell differentiation and granule exocytosis with T cells from mice expressing active fluorescent granzyme B.

Authors:  Pierre Mouchacca; Anne-Marie Schmitt-Verhulst; Claude Boyer
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

10.  Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.

Authors:  C Uyttenhove; J Maryanski; T Boon
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

View more
  2 in total

1.  Dynamic visualization of the whole process of cytotoxic T lymphocytes killing B16 tumor cells in vitro.

Authors:  Shuhong Qi; Hua Shi; Lei Liu; Lili Zhou; Zhihong Zhang
Journal:  J Biomed Opt       Date:  2019-03       Impact factor: 3.170

2.  Signal strength controls the rate of polarization within CTLs during killing.

Authors:  Gordon L Frazer; Christian M Gawden-Bone; Nele M G Dieckmann; Yukako Asano; Gillian M Griffiths
Journal:  J Cell Biol       Date:  2021-07-22       Impact factor: 8.077

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.